SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-030734
Filing Date
2023-03-10
Accepted
2023-03-09 21:02:31
Documents
5
Effectiveness Date
2023-03-10

Document Format Files

Seq Description Document Type Size
1 S-8 tm238252d1_s8.htm S-8 66784
2 EXHIBIT 5.1 tm238252d1_ex5-1.htm EX-5.1 12914
3 EXHIBIT 23.1 tm238252d1_ex23-1.htm EX-23.1 2089
4 EX-FILING FEES tm238252d1_ex-filingfees.htm EX-FILING FEES 18886
5 GRAPHIC tm238252d1_ex5-1img001.jpg GRAPHIC 3943
  Complete submission text file 0001104659-23-030734.txt   107465
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270435 | Film No.: 23721409
SIC: 2834 Pharmaceutical Preparations